Clinical Emergence and Genomic Characterization of Aztreonam-Avibactam-Resistant <i>Escherichia coli</i> ST410 Isolates in China. [PDF]
Li X +6 more
europepmc +1 more source
Characterization of phylogroups of <i>Klebsiella pneumoniae</i> (<i>K. quasipneumoniae</i> and <i>K. variicola</i>) harbouring <i>bla</i> <sub>OXA-232</sub>, with special reference to ceftazidime/avibactam/aztreonam synergy and their genetic profile. [PDF]
Banerjee T +4 more
europepmc +1 more source
<i>In vitro</i> susceptibility testing of aztreonam-avibactam against predominantly NDM-producing <i>Enterobacterales</i> in Peru. [PDF]
Garcia C +24 more
europepmc +1 more source
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolates. [PDF]
Viguier C +6 more
europepmc +1 more source
<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]
Yanagihara K +7 more
europepmc +1 more source
Responsible use of new antibiotics for critically ill patients suffering from infections due to carbapenem-resistant organisms-a narrative review for an enablement strategy. [PDF]
Eckmann C +16 more
europepmc +1 more source
A Comprehensive Review of the Underlying Mechanisms of Resistance and Therapeutic Options for DTR-PA in Bloodstream Infection and Pneumonia: A Clinical Vignette-Based Approach. [PDF]
Maraolo AE +11 more
europepmc +1 more source
Breaking the deadlock of metallo-β-lactamases: evidence and prospects for Aztreonam/Avibactam. [PDF]
Zhou J +17 more
europepmc +1 more source
Physicochemical Stability of Aztreonam/Avibactam in Elastomeric Devices for Outpatient Parenteral Antimicrobial Therapy. [PDF]
Toro Blanch C +8 more
europepmc +1 more source
In vitro activity of aztreonam/avibactam and comparators against Enterobacterales isolates from patients with hospital-acquired pneumonia, ventilator-associated pneumonia, and complicated intra-abdominal infections (ATLAS, 2021-2022). [PDF]
Yang Q +7 more
europepmc +1 more source

